2017
DOI: 10.1111/apa.13983
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal therapeutic hypothermia outside of standard guidelines: a survey of U.S. neonatologists

Abstract: Significant variability in practice exists when caring for infants with HIE who do not meet standard inclusion criteria, emphasizing the need for continued and rigorous research in this area.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…In 2013, a paper on the implementation of TH in the Netherlands and Flanders reported a successful introduction of this intervention with results similar to the major trials [5]. Currently, TH is the only clinically available therapy proven to be effective in infants with moderate to severe NE [6].…”
Section: Introductionmentioning
confidence: 99%
“…In 2013, a paper on the implementation of TH in the Netherlands and Flanders reported a successful introduction of this intervention with results similar to the major trials [5]. Currently, TH is the only clinically available therapy proven to be effective in infants with moderate to severe NE [6].…”
Section: Introductionmentioning
confidence: 99%
“…First, there are already systematic reviews that have consolidated the evidence in the preterm populations for the use of the GMA in the prediction of neurodevelopmental outcomes, but this does not exist for the older gestational age groups [ 15 , 16 ]. Secondly, the benefit of therapeutic hypothermia for NE caused by HIE is established in infants ≥ 35 weeks GA, and ongoing research considers the extension of therapeutic hypothermia treatment to a GA younger than 35 weeks [ 4 , 5 , 30 ].…”
Section: Methodsmentioning
confidence: 99%
“…Current eligibility criteria for therapeutic hypothermia has been determined by randomized controlled trials, supporting intervention in infants ≥ 35 weeks GA 41 . There are variations in practice with consideration for extension of treatment to younger gestational ages 42 . We therefore chose this GA to ensure we captured all the relevant literature.…”
Section: Participantsmentioning
confidence: 99%